Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PegBio Co., Ltd. Regulatory Filings 2012

Oct 31, 2012

50676_rns_2012-10-31_a76147b6-e12b-43b3-8325-9d075b3e6c53.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [110 x 24] intentionally omitted <==

==> picture [110 x 24] intentionally omitted <==

BEIJING YU SHENG TANG PHARMACEUTICAL GROUP LIMITED * 北京御生堂藥業集團有限公司

(Incorporated in Bermuda with limited liability)

(Stock Code: 1141)

CHANGE OF ADDRESS OF BERMUDA SHARE REGISTRAR

The Board of Directors (the “Board”) of Beijing Yu Sheng Tang Pharmaceutical Group Limited (the “Company”) hereby announces that with effect from 1 November 2012, the Company’s Bermuda principal share registrar and transfer agent “Butterfield Fulcrum Group (Bermuda) Limited” will change its address to:-

26 Burnaby Street Hamilton HM 11 Bermuda

The Company’s branch share registrar and transfer office in Hong Kong is still maintained by Tricor Tengis Limited of 26th Floor, Tesbury Centre, 28 Queen’s Road East, Wanchai, Hong Kong.

By Order of the Board Suen Cho Hung, Paul Chairman

Hong Kong, 31 October 2012

As at the date of this announcement, the Board comprises Mr. Suen Cho Hung, Paul (Chairman), Mr. Sue Ka Lok (Chief Executive Officer), Mr. Bai Jianjiang and Ms. Lee Chun Yeung, Catherine as Executive Directors and Mr. Wong Kwok Tai, Mr. Weng Yixiang and Mr. Lu Xinsheng as Independent Non-executive Directors.

* For identification purpose only